Sponsor content
851 result(s) found, displaying 631 to 640
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VALGAN valganciclovir (as hydrochloride) 450 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALOCIP palonosetron hydrochloride 250 microgram/5 mL solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA PALONOSETRON palonosetron hydrochloride 250 microgram/5 mL solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALONOSETRON CIPLA palonosetron hydrochloride 250 microgram/5 mL solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TADACIP 10 tadalafil 10 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TADACIP 20 tadalafil 20 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TADACIP 5 tadalafil 5 mg film-coated tablet blister pack.